Current Opinion in Organ Transplantation

Papers
(The TQCC of Current Opinion in Organ Transplantation is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial: Organ Preservation Revolution: the future is revisiting the past through a different lens57
Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?28
Delayed graft function: current status and future directions26
Urine CXCL10 as a biomarker in kidney transplantation25
HLA-DQ antibodies in alloimmunity, what makes them different?25
Overview of pregnancy in solid-organ transplantation21
Editorial introductions21
Deceased donors with multidrug-resistant organisms: implications and future directions19
The perspective for next-generation lung replacement therapies: functional whole lung generation by blastocyst complementation19
Update on surgical management of enteroatmospheric fistulae in intestinal failure patients19
Using organ perfusion to optimize donor livers18
Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients17
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation17
Obesity and kidney transplantation17
Equity in liver transplantation: are we any closer?16
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?15
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions14
Modifying organs with gene therapy and gene modulation in the age of machine perfusion14
The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes14
What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?14
Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease12
Respiratory viral infections including COVID-19 in solid organ transplantation12
Establishing an upper extremity transplantation program: lessons learnt over 12 years12
Regulatory dendritic cell therapy in organ transplantation11
Language and cultural concordance to promote equity in organ transplantation for Hispanics with limited English proficiency11
The sex disparity in liver transplantation11
Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients10
Cardiac evaluation of the liver transplant candidate10
Beyond donation to organ utilization in the UK9
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients9
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation9
A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum9
Management of the sensitized heart transplant candidate9
Ethical issues in organ procurement: donation after normothermic regional perfusion in liver transplantation9
A cystic fibrosis patient9
Machine perfusion in liver transplantation: recent advances and coming challenges9
Donor-derived infections in solid organ transplant recipients9
Social support and transplantation8
Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for?8
Living liver donor pain management8
Future directions for xenotransplantation in lungs8
Nontransplant options for portomesenteric thrombosis7
The road to xenotransplantation7
Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions7
Lung preservation: from perfusion to temperature7
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation7
Ethical considerations in lung re-transplantation7
Normothermic regional perfusion for donation after circulatory death donors7
Editorial introductions7
Grasping time – longevity of vascularized composite allografts7
Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview7
Management of long-term cardiovascular risk factors post organ transplant: Erratum7
The role of living donor liver transplantation in colorectal cancer liver metastases6
Cell-free DNA in lung transplantation: research tool or clinical workhorse?6
Social and biologic determinants in lung transplant allocation6
Advances in desensitization for human leukocyte antigen incompatible kidney transplantation6
Expanding MELD exceptions for colorectal liver metastasis: data and policy6
DSA in solid organ transplantation: is it a matter of specificity, amount, or functional characteristics?6
Kidney organ allocation: reducing discards6
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how6
Adherence in transplantation6
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics6
Editorial introductions6
Pediatric intestinal rehabilitation6
Editorial introductions6
Optimizing cardiac status in the preliver transplant candidate6
Potential options to expand the intestinal donor pool: a comprehensive review6
Editorial introduction6
0.14580917358398